Covered recipient · General Payments record
JULIA M LARA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2021–2024
$1,098.26
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $369.61 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $140.93 | 5 |
| Lilly USA, LLC | $53.36 | 3 |
| E.R. Squibb & Sons, L.L.C. | $48.35 | 3 |
| ABBVIE INC. | $36.85 | 2 |
| CeQur Corporation | $29.09 | 1 |
| DEXCOM, INC. | $24.87 | 1 |
| Exact Sciences Corporation | $20.33 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $7.31 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125094475 | CMS |
| Abbott Laboratories | $92.40 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125094477 | CMS |
| Abbott Laboratories | $17.83 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125094479 | CMS |
| Abbott Laboratories | $7.07 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125094481 | CMS |
| Abbott Laboratories | $16.32 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125094483 | CMS |
| ABBVIE INC. | $13.59 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107509879 | CMS |
| ABBVIE INC. | $23.26 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107509881 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.83 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147003154 | CMS |
| CeQur Corporation | $29.09 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099649751 | CMS |
| Dexcom, Inc. | $24.87 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153368511 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.24 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101645337 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.85 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101645352 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.26 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101645359 | CMS |
| Exact Sciences Corporation | $20.33 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114519778 | CMS |
| Lilly USA, LLC | $15.19 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135701716 | CMS |
| Lilly USA, LLC | $15.98 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135728755 | CMS |
| Lilly USA, LLC | $22.19 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135720149 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.